For the three months ended June 30, 2021, we had net income of $20,536,286, which consists of the change in fair value of warrant liabilities of $22,657,500, interest income on marketable securities held in the Trust Account of $28,675, offset by general and administrative expenses of $2,149,889.
For the six months ended June 30, 2021, we had net income of $45,610,291, which consists of the change in fair value of warrant liabilities of $48,152,500, interest income on marketable securities held in the Trust Account of $57,035, offset by general and administrative expenses of $2,599,244.
Liquidity and Capital Resources
On October 14, 2020, we consummated the Initial Public Offering of 115,000,000 Units, inclusive of the underwriters’ election to fully exercise their option to purchase an additional 15,000,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $1,150,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 11,000,000 private placement warrants to the Sponsor at a price of $2.00 per private placement warrant generating gross proceeds of $22,000,000.
Following the Initial Public Offering, the exercise of the over-allotment option in full and the sale of the private placement warrants, a total of $1,150,000,000 was placed in the Trust Account and we had $1,584,406 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred $60,816,147 in transaction costs, including $20,000,000 of underwriting fees, $40,250,000 of deferred underwriting fees and $566,147 of other offering costs. Of the total transaction costs incurred, $2,246,990 was recognized as an expense in the condensed statements of operations as this amount related to the warrants recognized as liabilities.
For the six months ended June 30, 2022, net cash used in operating activities was $420,019, consisting of net income of $59,001,785 which is affected by a change in fair value of warrant liabilities of $58,830,000, and interest earned on marketable securities held in the Trust Account of $1,563,375. Changes in operating assets and liabilities provided $971,571 of cash from operating activities.
For the six months ended June 30, 2021, net cash used in operating activities was $661,025, consisting of net income of $45,610,291 affected by a change in fair value of warrant liabilities of $48,152,500, and interest earned on marketable securities held in the Trust Account of $57,035. Changes in operating assets and liabilities provided $1,938,219 of cash from operating activities.
At June 30, 2022 and December 31, 2021, we had investments held in the Trust Account of $1,151,702,972 and $1,150,139,597, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account, to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
At June 30, 2022 and December 31, 2021, we had cash of $70,866 and $37,298, respectively, held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.
On September 30, 2021, we issued a promissory note to the Sponsor for an aggregate amount of up to $2,500,000 (the “Promissory Note”). The Promissory Note is non-interest bearing and is due and payable in full on the earlier of (i) October 14, 2022 and (ii) the effective date of a Business Combination. As of June 30, 2022 and December 31, 2021, there was $1,262,500 and $812,500 outstanding under the Promissory Note, respectively.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to (other than pursuant to the Promissory Note), loan us additional funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment.